2023
DOI: 10.1002/cbf.3895
|View full text |Cite
|
Sign up to set email alerts
|

A better understanding of the role of the CTLA–CD80/86 axis in the treatment of autoimmune diseases

Zahra Darvish,
Ramiar Kamal Kheder,
Tola Abdulsattar Faraj
et al.

Abstract: Autoimmune diseases are diseases in which the regulatory mechanisms of the immune response are disturbed. As a result, the body loses self‐tolerance. Since one of the main regulatory mechanisms of the immune response is the CTLA4–CD80/86 axis, this hypothesis suggests that autoimmune diseases potentially share a similar molecular basis of pathogenesis. Hence, investigating the CTLA4–CD80/86 axis may be helpful in finding an appropriate treatment strategy. Therefore, this study aims to investigate the molecular… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 89 publications
0
1
0
Order By: Relevance
“…CD86, also named B7-2, is one out of eleven members of the B7 family. It is a monomeric protein expressed on the surface of several antigen-presenting cells (APC) such as microglia, macrophages, dendritic cells, B and T cells ( Darvish et al, 2023 ), and endothelial cells ( Prat et al, 2000 ; Girvin et al, 2002 ). Given that, in the brain tissue, CD86 is expressed constitutively and preferentially on microglia and, besides, it is upregulated in inflammatory microglia, it has been used as a marker of inflammatory state of reactive microglia ( Jurga et al, 2020 ; Paolicelli et al, 2022 ).…”
Section: Methodsmentioning
confidence: 99%
“…CD86, also named B7-2, is one out of eleven members of the B7 family. It is a monomeric protein expressed on the surface of several antigen-presenting cells (APC) such as microglia, macrophages, dendritic cells, B and T cells ( Darvish et al, 2023 ), and endothelial cells ( Prat et al, 2000 ; Girvin et al, 2002 ). Given that, in the brain tissue, CD86 is expressed constitutively and preferentially on microglia and, besides, it is upregulated in inflammatory microglia, it has been used as a marker of inflammatory state of reactive microglia ( Jurga et al, 2020 ; Paolicelli et al, 2022 ).…”
Section: Methodsmentioning
confidence: 99%